Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (HHSN271201200034C)
Neurocritical Care Society (N/A)
CHI Baylor St Luke's Medical Center (N/A)
Article History
First Online: 29 May 2019
Compliance with Ethical Standards
:
: Dr. Macdonald reports personal fees from Edge Therapeutics and grants from Brain Aneurysm Foundation, outside the submitted work. Dr. Chou reports research grants from National Institute of Health/NINDS (K23-NS0738060, the University of Pittsburgh Physicians, and the University of Pittsburgh School of Medicine. Outside the submitted work, Dr. Chou received fees from Edge Therapeutics (site principal investigator, consulting), non-financial support from Merck, consulting fees from the National Institute of Health. Dr. Chou is a co-inventor on a patent MITOCHONDRIAL BIOMARKERS OF, AND THERAPEUTICS AQ15 FOR, CNS INJURY AND DISEASE filed in the United States Patent and Trademark Office as Application 62/3817.
: This work did not involve human or animal participants.